| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_PDS5B_0016500 | Exon-Exon | chr13:33268360-33309467 | chr13:32694223-32735330 | 937 nt | 0.3970 |
| hsa_PDS5B_0016600 | Exon-Exon | chr13:33268360-33315286 | chr13:32694223-32741148 | 1006 nt | 0.3976 |
| hsa_PDS5B_0016700 | Exon-Exon | chr13:33268360-33320238 | chr13:32694223-32746100 | 1267 nt | 0.3946 |
| hsa_PDS5B_0016800 | Exon-Exon | chr13:33268360-33327674 | chr13:32694223-32753536 | 1472 nt | 0.4001 |
| hsa_PDS5B_0016900 | Exon-Exon | chr13:33268360-33334858 | chr13:32694223-32760720 | 2049 nt | 0.3914 |
| hsa_PDS5B_0017500 | Exon-Exon | chr13:33270991-33284243 | chr13:32696854-32710106 | 572 nt | 0.3951 |
| hsa_PDS5B_0019100 | Exon-Exon | chr13:33275460-33284243 | chr13:32701323-32710106 | 383 nt | 0.3943 |
| hsa_PDS5B_0019200 | Exon-Exon | chr13:33275460-33309467 | chr13:32701323-32735330 | 666 nt | 0.4009 |
| hsa_PDS5B_0019300 | Exon-Exon | chr13:33275460-33330094 | chr13:32701323-32755956 | 1316 nt | 0.3959 |
| hsa_PDS5B_0019400 | Exon-Intergenic | chr13:33275460-33352158 | chr13:32701323-32778020 | 250 nt | 0.2800 |
A study in humans identified circPDS5B as a biomarker positively correlated with infarct volume in acute ischemic stroke patients [Wei et al. DOI:10.1186/s12883-021-02397-0]. A study in humans demonstrated that hsa_circRNA_0004494, a circular RNA, was significantly downregulated in peripheral blood mononuclear cells from heart failure patients with sacubitril/valsartan resistance compared to non-resistant patients following acute myocardial infarction, as validated by quantitative real-time PCR in 18 sample pairs [Su et al. DOI:10.1016/j.ejphar.2023.175547].